Q BioMed (QBIO) News Today → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free QBIO Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 11, 2024 | msn.comClearside Biomedical Q4 2023 Earnings PreviewFebruary 24, 2024 | benzinga.comQ BioMed Stock (OTC:QBIO) Dividends: History, Yield and DatesFebruary 13, 2024 | msn.comBiogen Inc. (BIIB) Lags Q4 Earnings and Revenue EstimatesJanuary 28, 2024 | msn.comBioxyne’s Q2 FY24 revenue surpasses $2.5m on Aussie medicinal cannabis growthNovember 16, 2023 | morningstar.comQ BioMed Inc QBIOAugust 18, 2023 | seekingalpha.comQBIO Q BioMed Inc.April 14, 2023 | proactiveinvestors.comQ BioMed receives US patent and notice of allowance in Europe for Uttroside B; seeks ways to boost shareholder valueApril 14, 2023 | finance.yahoo.comQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for EuropeMarch 3, 2023 | benzinga.comQ BioMed Stock (OTC:QBIO), Quotes and News SummaryFebruary 10, 2023 | proactiveinvestors.comQ BioMed gets notice of allowable US patent for liver cancer treatment Uttroside BFebruary 10, 2023 | finance.yahoo.comQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent OfficeJanuary 12, 2023 | benzinga.comShort Volatility Alert: Q Biomed IncJanuary 1, 2023 | finance.yahoo.comQ BioMed Inc. (QBIO)November 14, 2022 | proactiveinvestors.comQ BioMed boosted by multi-million dollar asset as it converts long-term royalty into equity stake in Mannin ResearchNovember 14, 2022 | finance.yahoo.comQ BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC.October 11, 2022 | prnewswire.comQ BIOMED PROVIDES SHAREHOLDER UPDATESeptember 27, 2022 | proactiveinvestors.comQ Biomed announces patent for groundbreaking GDF15 biomarker for glaucoma detection and treatmentSeptember 27, 2022 | finance.yahoo.comQ BIOMED ANNOUNCES ISSUANCE OF PATENT FOR GROUNDBREAKING GDF15 BIOMARKERAugust 25, 2022 | finance.yahoo.comTraders News Source Senior Editor Mark Roberts Interviews Denis D Corin, CEO and Chairman Q BioMed Inc.July 29, 2022 | finance.yahoo.comQ BioMed Inc. Provides Update to ShareholdersJuly 26, 2022 | proactiveinvestors.comQ BioMed welcomes study that highlights the safety and efficacy of Uttroside-B chemotherapeuticJuly 26, 2022 | finance.yahoo.comQ BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancerMay 11, 2022 | investing.comQ BioMed Inc (QBIO)May 6, 2022 | proactiveinvestors.comQ BioMed says its strategy is paying off as it outlines its value proposition in multibillion-dollar marketsMay 6, 2022 | finance.yahoo.comQ BioMed Outlines Strategy and Value Proposition in Multi-Billion Dollar MarketsMarch 16, 2022 | proactiveinvestors.comQ BioMed announces publication of research supporting efficacy and development of its Uttroside-B chemotherapeutic to treat liver cancerMarch 16, 2022 | finance.yahoo.comQ BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancerMarch 7, 2022 | seekingalpha.comQ BioMed expands Strontium89 to Chinese market with $500K orderMarch 7, 2022 | finance.yahoo.comQ BioMed Announces Initial $500k Order of Strontium89 to Chinese MarketFebruary 14, 2022 | proactiveinvestors.comQ BioMed outlines strategic direction and goals for 2022February 14, 2022 | finance.yahoo.comQ BioMed Outlines Strategic Direction for 2022December 16, 2021 | proactiveinvestors.comQ BioMed says it is seeing a ‘significant uptrend’ in revenues as it continues to roll out Strontium89December 16, 2021 | proactiveinvestors.comNA Proactive news snapshot: Q BioMed Inc, FansUnite Entertainment Inc, BioSig Technologies Inc, Endexx Corporation, Doré Copper ...December 16, 2021 | finance.yahoo.comQ BioMed Shows Significant Uptrend in Revenues in Year-End UpdateNovember 8, 2021 | proactiveinvestors.comQ BioMed to forms partnership with EVERSANA to help commercialize Strontium89November 8, 2021 | finance.yahoo.comQ BioMed Bolsters Commercialization of Strontium89 with EVERSANA PartnershipOctober 26, 2021 | proactiveinvestors.comQ BioMed raises $2M with plans for uplisting on NASDAQ; updates on activity for coming monthsOctober 25, 2021 | finance.yahoo.comQ BioMed Inc. Provides Shareholder UpdateSeptember 28, 2021 | proactiveinvestors.comQ BioMed sees uptick in 4Q sales of Strontium89 amid commercial rolloutSeptember 28, 2021 | finance.yahoo.comQ BioMed Inc. Provides Update on Strontium89 Commercial Roll Out Revenue Up in 4th Quarter with Positive TrendSeptember 22, 2021 | finanznachrichten.deFinancialNewsMedia.com: Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and VariantsSeptember 22, 2021 | finance.yahoo.comQ BioMed Inc. Updates on COVID-19 Therapeutic Development and Clinical Trials - MAN-19 therapeutic program heading to clinical trial in early 2022August 25, 2021 | proactiveinvestors.comQ BioMed expects to receive South Korean patent for its liver cancer chemotherapy candidateAugust 24, 2021 | finance.yahoo.comQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent in South Korea and Shows Promising Results in Initial Pre-Clinical TestingAugust 10, 2021 | proactiveinvestors.comQ BioMed strikes distribution agreement for Strontium89 sales in CanadaAugust 10, 2021 | finance.yahoo.comQ BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada Get Q BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address This is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open. Click now for the best way into the newest AI projects QBIO Media Mentions By Week QBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QBIO News Sentiment▼0.000.56▲Average Medical News Sentiment QBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QBIO Articles This Week▼00▲QBIO Articles Average Week Get Q BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PPCB News WCUI News CALA News STAB News PRED News AMPE News ACUR News XSNX News ATHX News USRM News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:QBIO) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldBiden to Drop BOMBSHELL June 13th?Paradigm PressForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q BioMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
